![PDF] Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients. | Semantic Scholar PDF] Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1dc6ef9b56e8fabae5d2f72028fa33890076785c/2-Table1-1.png)
PDF] Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients. | Semantic Scholar
![Frontiers | Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers Frontiers | Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers](https://www.frontiersin.org/files/Articles/669774/fonc-11-669774-HTML-r1/image_m/fonc-11-669774-g001.jpg)
Frontiers | Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers
![Beta-2 Microglobulin as a Diagnostic Parameter in Non-Hodgkin Lymphoma: A Comparative Study with FDG-PET | Anticancer Research Beta-2 Microglobulin as a Diagnostic Parameter in Non-Hodgkin Lymphoma: A Comparative Study with FDG-PET | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/33/8/3341/F1.large.jpg)
Beta-2 Microglobulin as a Diagnostic Parameter in Non-Hodgkin Lymphoma: A Comparative Study with FDG-PET | Anticancer Research
![Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis - ScienceDirect Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0021915021000356-fx1.jpg)
Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis - ScienceDirect
![Frontiers | Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases Frontiers | Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases](https://www.frontiersin.org/files/Articles/273558/fmed-04-00073-HTML/image_m/fmed-04-00073-t001.jpg)
Frontiers | Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases
![Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy - ScienceDirect Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0304383521002937-gr1.jpg)
Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy - ScienceDirect
![Beta-2 Microglobulin (Renal Failure and Tumor Marker) Recombinant Monoclonal Antibody (B2M/7013R) (567-RBM8-P1) Beta-2 Microglobulin (Renal Failure and Tumor Marker) Recombinant Monoclonal Antibody (B2M/7013R) (567-RBM8-P1)](https://www.thermofisher.com/antibody/images/650/567-RBM8-P1-BETA-2MICROGLOBULIN-IHCP-1-20220223_145423.jpg?time=20220826)
Beta-2 Microglobulin (Renal Failure and Tumor Marker) Recombinant Monoclonal Antibody (B2M/7013R) (567-RBM8-P1)
![PDF] Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor | Semantic Scholar PDF] Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/21d5f48fd53c1374a33f12238f80637418a53b96/2-Table2-1.png)
PDF] Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor | Semantic Scholar
![B2M overexpression correlates with malignancy and immune signatures in human gliomas | Scientific Reports B2M overexpression correlates with malignancy and immune signatures in human gliomas | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-84465-6/MediaObjects/41598_2021_84465_Fig1_HTML.png)